Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Revue Du Rhumatisme (English Ed.)
|
December 16, 1998
Animal models of antiphospholipid syndrome
A Tincani, L Spatola, M Cinquini, et al.
Lupus
|
November 14, 1998
Anti beta2-glycoprotein I antibodies: clinical significance
A Tincani, L Spatola, M Cinquini, et al.
La Clinica Terapeutica
|
April 30, 1983
[Letosteine in chronic obstructive bronchopneumopathy]
P Meroni, G Palmieri, G De Bartolo, et al.
Clinical and Experimental Rheumatology
|
February 10, 2006
Mechanisms of immune-mediated skin diseases: an overview
S Beissert, I Cavazzana, F Mascia, et al.
Circulation
|
April 1, 1998
Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome
J George, M Blank, Y Levy, et al.
Cytokine
|
May 1, 1996
Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment
F Nicoletti, F Patti, R DiMarco, et al.
Hepatology (Baltimore, Md.)
|
September 26, 2000
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism
F Nicoletti, R Di Marco, P Zaccone, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 14, 1998
Sodium fusidate in Gillain-Barré syndrome: a case report
F Nicoletti, A Nicoletti, S Giuffrida, et al.
Autoimmunity
|
February 19, 2000
Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency
R Di Marco, M Xiang, P Zaccone, et al.
Clinical and Experimental Immunology
|
September 20, 2015
First steps in the standardization of immunoglobulin IgG myeloperoxidase-anti-neutrophil cytoplasmic antibody measurements
D P Hutu, E Tuddenham, E Monogioudi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Revue Du Rhumatisme (English Ed.)
|
December 16, 1998
Animal models of antiphospholipid syndrome
A Tincani, L Spatola, M Cinquini, et al.
Lupus
|
November 14, 1998
Anti beta2-glycoprotein I antibodies: clinical significance
A Tincani, L Spatola, M Cinquini, et al.
La Clinica Terapeutica
|
April 30, 1983
[Letosteine in chronic obstructive bronchopneumopathy]
P Meroni, G Palmieri, G De Bartolo, et al.
Clinical and Experimental Rheumatology
|
February 10, 2006
Mechanisms of immune-mediated skin diseases: an overview
S Beissert, I Cavazzana, F Mascia, et al.
Circulation
|
April 1, 1998
Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome
J George, M Blank, Y Levy, et al.
Cytokine
|
May 1, 1996
Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment
F Nicoletti, F Patti, R DiMarco, et al.
Hepatology (Baltimore, Md.)
|
September 26, 2000
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism
F Nicoletti, R Di Marco, P Zaccone, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 14, 1998
Sodium fusidate in Gillain-Barré syndrome: a case report
F Nicoletti, A Nicoletti, S Giuffrida, et al.
Autoimmunity
|
February 19, 2000
Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency
R Di Marco, M Xiang, P Zaccone, et al.
Clinical and Experimental Immunology
|
September 20, 2015
First steps in the standardization of immunoglobulin IgG myeloperoxidase-anti-neutrophil cytoplasmic antibody measurements
D P Hutu, E Tuddenham, E Monogioudi, et al.
Page
of 5